BlueYard Capital — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Agnostic is a data and AI consultancy that designs and operates high-performance ClickHouse clusters, real-time data pipelines, and production LLM/RAG systems for clients across industries.
AI & Machine LearningData & InfrastructureDeveloper Tools
Didier Franc(Founder)in
Co-investorsKima VenturesTRGC
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsHAWKTAILOctopus VenturesAcequia Capital (AceCap)Amino CollectiveredalpineWilbe Capital
Singapore-based maker of a browser extension whose AI-driven, blockchain-backed virtual pets live on the user's screen.
Crypto & Web3FintechGamingSingapore, SG
Co-investorsTechstarsAcequia Capital (AceCap)Protocol Labs
Transcripta Bio develops medicines for patients with serious diseases by mapping how molecules affect human cells at single-cell resolution.
AI & Machine LearningBiotechDeep Tech
Co-investorsJAZZ Venture PartnersARCH Venture PartnersDCVC BioInsight PartnersMayo Clinic Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















